[Therapeutic effect of blood activating polypeptide on the treatment of chronic severe viral hepatitis].
To study the therapeutic effect of blood activating polypeptide on chronic severe viral hepatitis (CSH) and the method used. The treated group included 50 CSH patients (male 82, female 8, age 39 +/- 9). Based on routine treatments, they were intravenously injected with 15 ml blood activating polypeptide dissolved in 250 ml of 10% glucose, qd x 4 wks. The control group contained 50 CSH patients (male 3, female 7, age 38+/-12). They were only treated with routine treatments for liver protection, jaundice regression, health maintenance, anti-infection and diuresis. The SB and ALT in treated patients decreased obviously (P < 0.01) after treatment, the prominent efficacy was 52%, the total efficacy was 86%, all were superior to the control group. Blood activating polypeptide is safe, reliable and effective in the treatment of CSH.